Australia, April 14 -- Incyte Holdings Corp., owns the trademark (2615983) for 'MINJUVI' and 'GREEK CROSS,DIVIDED' till Oct. 10, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of auto-immune disorders.] and 44 [Providing medical information via a website; Providing medical information to healthcare providers and patients relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders.]
Type of Mark: Figurative
Date of Acceptance: Feb. 2
Registration Advertised: April 13
For further details contact Makiko Coffland.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2615983.
Disclaimer: Curated by HT Syndication.
